Delivery Order SPE2DB25D3005-SPE2DB25FQEQA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,053.06, represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $48,118.52 delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of $8,026.53 with a firm fixed price structure and an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,026.53 and an ultimate completion date of September 17, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as both the place of performance...
- The Defense Logistics Agency awarded a $8,026.53 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,447.69 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,418.06 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract carries a firm fixed price structure and a completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQEQADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,029.63 to supply Promacta 75 mg tablets (30-count units) with a completion deadline of May 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on April 24, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to serve as a comprehensive global pharmaceutical supplier for military healthcare programs, delivering a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive federal pharmaceutical distribution capabilities support military medical supply chains and healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through flexible ordering mechanisms that allow for recurring pharmaceutical needs across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 4/24/25 |